Antitumor activity and mode of action of 2-thio-6-azauridine (NSC-146268) on L1210 leukemia.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001380:Azauridine / Q000627:therapeutic use* / Q000031:analogs & derivatives; D002250:Carbon Radioisotopes; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D004273:DNA, Neoplasm / Q000096:biosynthesis; D007930:Leucine / Q000378:metabolism; D007939:Leukemia L1210 / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism; D051379:Mice; D009963:Orotic Acid / Q000037:antagonists & inhibitors / Q000378:metabolism; D012334:RNA, Neoplasm / Q000096:biosynthesis; D013871:Thiones / Q000627:therapeutic use; D013891:Thiouridine / Q000031:analogs & derivatives; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D000970:Antineoplastic Agents; D002250:Carbon Radioisotopes; D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D013871:Thiones; D014316:Tritium; D013891:Thiouridine; C009456:2-thio-6-azauridine; D009963:Orotic Acid; D001380:Azauridine; D002262:Carboxy-Lyases; D007930:Leucine; D013936:Thymidine; D014529:Uridine